|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.62 EUR | -1.54% |
|
-3.72% | -10.21% |
| Dec. 15 | BofA maintains its buy rating on Eramet, with a target price of €64 |  |
| Dec. 09 | Oddo BHF Maintains Negative Stance on Eramet Despite Raised Target | |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
 | 3.04B | 0.48% | 3.31% | 0.92% | - | 3.5x | |
| 51.26B | 17.59% | 39.48% | 21.97% | 9.62% | 0.5x | |
| 53.66B | 21.53% | 30.73% | 21.04% | 11.2% | 0.24x | |
| 16.17B | 22% | 43.31% | 18.07% | 9.86% | 0.18x | |
| 8.67B | 8.82% | 19.22% | 5.84% | 2.53% | 1.8x | |
| 231B | -0.71% | 3% | 8.76% | 2.9% | 2.54x | |
| 27.29B | -11.24% | 18.37% | 8.46% | 2.95% | 1.26x | |
| 3.5B | 4.03% | 27.05% | 7.01% | 4.62% | -0.3x | |
| 3.98B | 30.26% | 40.22% | 72.08% | 30.09% | 0.11x | |
| 17.9B | 9.8% | 20.43% | 41.67% | 7.61% | 1.59x | |
| 9.39B | 3.01% | 12.11% | 1.53% | 0.79% | -0.41x | |
| 2.82B | 3.96% | 15.48% | 6.06% | - | -0.15x | |
| 6.66B | - | 15.86% | 1.73% | - | 0.39x | |
| 4.12B | -4.94% | 22.36% | 6.22% | -2.24% | 0.97x | |
| 40.82M | 558.91% | -351.3% | 5.25% | - | 0.4x | |
| 7.61B | 2.8% | 15.91% | 7.48% | 4.76% | -0.06x | |
| 167M | 15.03% | 26.36% | 2.05% | 2.16% | 1.38x | |
| 1.86B | 16% | 23.41% | 17.9% | 12.6% | - | |
| 504M | -25.49% | -18.7% | -2.6% | -1.96% | -3.01x | |
| 753M | 8.29% | 16.28% | 3.62% | 2.17% | - | |
| Average | 22.52B | 35.8% | 1.15% | 12.75% | 6.23% | 0.61x | |
| Weighted average by Cap. | 44.4B | 22.95% | 19.65% | 16.84% | 7.89% | 0.66x |
- Stock Market
- Equities
- ERA Stock
- Sector Eramet
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
